Rare diseases
Investigational molecules
Locations
Study on the Effects of Durvalumab and Tazemetostat for Adults with Advanced Solid Tumors
FranceStudy on Durvalumab, Olaparib, and Chemotherapy for Patients with Advanced or Recurrent Endometrial Cancer in Spain
SpainStudy of Olaparib, Durvalumab and UV1 combination as maintenance treatment for patients with recurrent ovarian cancer who do not have BRCA mutations
AustriaStudy of Durvalumab and Tremelimumab for Patients with Resectable Liver Cancer
ItalyStudy of Durvalumab with Chemoradiation Therapy for Patients with Unresectable, Locally Advanced Non-small Cell Lung Cancer
HungaryStudy Comparing Ceralasertib and Durvalumab with Docetaxel for Patients with Advanced Non-Small Cell Lung Cancer After Previous Treatments
BelgiumStudy on Durvalumab and Domvanalimab for Patients with Stage III Unresectable Non-Small Cell Lung Cancer After Chemoradiation Therapy
BelgiumStudy on Durvalumab and Platinum-Based Drug Combination for Patients with Stage IIB-IIIB Non-Small Cell Lung Cancer
AustriaStudy on Alectinib and Durvalumab for Patients with Locally Advanced, Unresectable Stage III Non-Small Cell Lung Cancer
BelgiumStudy on Durvalumab with Oleclumab or Monalizumab for Patients with Stage III Unresectable Non-Small Cell Lung Cancer After Chemoradiation Therapy
FranceStudy on the Effectiveness of Durvalumab and Bevacizumab with TACE in Patients with Localized Liver Cancer
FranceStudy on the Effectiveness and Safety of Durvalumab with Gemcitabine and Cisplatin for Patients with Muscle-Invasive Bladder Cancer
BelgiumTell us about your condition – we search every trial in Europe and connect you with the right site.
